iVeena publishes Proof of Concept studies for Post Surgery Cataract Inflammation products

20 November 2013

iVeena has demonstrated safety and efficacy in 42 rabbit eyes in treating post-surgical inflammation and retinal thickening (as measured by optical coherence tomography). iVeena has also demonstrated appropriate and desired first-order release kinetics of dexamethasone. iVeena has been able to reproducibly manufacture implants using a method of hot-melt extrusion that is scalable, operable with our equipment, in a clean-room GMP environment, and sterilizable with e-beam radiation and package-able with a vacuum sealed pouch.